Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
Conditions: Schizophrenia Agitation; Schizo Affective Disorder; Bipolar Disorder; Dexmedetomidine Interventions: Drug: Dexmedetomidine; Drug: Lorazepam 2 MG/ML Sponsors: Temple University; BioXcel Therapeutics Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
Conditions: Depression, Anxiety; Fear; Depression; Anxiety and Fear; Anxiety Disorders; Anxious Depression Interventions: Drug: Lorazepam; Other: Placebo Sponsors: Laureate Institute for Brain Research, Inc.; National Institute of Mental Health (NIMH); California Institute of Technology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects
Condition: Healthy Interventions: Drug: LSD (150 µg) + ketanserin (40 mg); Drug: LSD (150 µg) + olanzapine (10 mg); Drug: LSD (150 µg) + lorazepam (2 mg); Drug: LSD (150 µg) + placebo; Drug: Placebo + placebo Sponsor: University Hospital, Basel, Switzerland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
